ATE545867T1 - I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom - Google Patents

I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom

Info

Publication number
ATE545867T1
ATE545867T1 AT08826976T AT08826976T ATE545867T1 AT E545867 T1 ATE545867 T1 AT E545867T1 AT 08826976 T AT08826976 T AT 08826976T AT 08826976 T AT08826976 T AT 08826976T AT E545867 T1 ATE545867 T1 AT E545867T1
Authority
AT
Austria
Prior art keywords
plastin
test method
vitro diagnosis
colorectal carcinoma
diagnosis
Prior art date
Application number
AT08826976T
Other languages
English (en)
Inventor
Monique Arpin
Nicole Battail-Poirot
Corinne Beaulieu
Jean-Philippe Charrier
Genevieve Choquet-Kastylevsky
Original Assignee
Biomerieux Sa
Centre Nat Rech Scient
Inst Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa, Centre Nat Rech Scient, Inst Curie filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE545867T1 publication Critical patent/ATE545867T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT08826976T 2007-07-19 2008-07-10 I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom ATE545867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705198A FR2919061B1 (fr) 2007-07-19 2007-07-19 Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
PCT/FR2008/051294 WO2009019369A2 (fr) 2007-07-19 2008-07-10 Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal

Publications (1)

Publication Number Publication Date
ATE545867T1 true ATE545867T1 (de) 2012-03-15

Family

ID=39092068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08826976T ATE545867T1 (de) 2007-07-19 2008-07-10 I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom

Country Status (9)

Country Link
US (1) US8445211B2 (de)
EP (1) EP2171466B1 (de)
JP (1) JP5417327B2 (de)
CN (1) CN101765774B (de)
AT (1) ATE545867T1 (de)
AU (1) AU2008285558B2 (de)
CA (1) CA2695191C (de)
FR (1) FR2919061B1 (de)
WO (1) WO2009019369A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
US20120244141A1 (en) * 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
US20120172244A1 (en) 2010-12-20 2012-07-05 Steven Buechler Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
WO2012088146A2 (en) * 2010-12-20 2012-06-28 The University Of Notre Dame Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
CN108611368A (zh) * 2018-05-04 2018-10-02 国家纳米科学中心 一种pls3-abd2重组蛋白的制备方法
CN113999817B (zh) * 2021-10-28 2022-10-21 杭州博茵生物技术有限公司 半乳糖凝集素-3鼠杂交瘤细胞、单克隆抗体、检测试剂盒及检测方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920484A1 (de) 1979-05-21 1980-12-04 Bosch Gmbh Robert Messeinrichtung mit magnetischem kreis zum messen eines gleichstroms
US4529931A (en) 1983-04-07 1985-07-16 Ford Motor Company Single-coil current measuring circuit
US5360715A (en) * 1988-06-07 1994-11-01 California Institute Of Technology Plastin isoforms and their uses
US5002870A (en) * 1988-06-07 1991-03-26 California Institute For Medical Research Plastin isoforms and their use
JP2816175B2 (ja) 1989-04-28 1998-10-27 三菱電機株式会社 直流電流測定装置
US5223789A (en) 1989-06-23 1993-06-29 Fuji Electric Co., Ltd. AC/DC current detecting method
JPH0464068A (ja) 1990-07-02 1992-02-28 Fuji Electric Co Ltd 直流電流検出方法
CA2054149A1 (en) 1990-10-29 1992-04-30 Eric Pringault Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals
US6291205B1 (en) 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
US6001632A (en) 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
DE19642472A1 (de) 1996-10-15 1998-04-16 Abb Research Ltd Flußkompensierter Stromsensor
CA2353546C (en) 1998-12-01 2009-05-19 Wrair Diagnosis of stage or aggressiveness of cancer
JP2002536995A (ja) 1999-02-22 2002-11-05 インサイト・ファーマスーティカルズ・インコーポレイテッド 結腸の疾患に関連する遺伝子
EP1171771B1 (de) 1999-04-09 2005-06-29 Rigshospitalet Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker
AU7721500A (en) 1999-09-29 2001-04-30 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
WO2002020731A2 (en) 2000-09-08 2002-03-14 Bayer Aktiengesellschaft Regulation of human protein disulfide isomerase-like enzyme
AU2001294943A1 (en) 2000-10-02 2002-04-15 Bayer Corporation Nucleic acid sequences differentially expressed in cancer tissue
US20020160382A1 (en) 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US7691567B2 (en) 2000-10-30 2010-04-06 Board Of Regents, The University Of Texas System Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
US20030082533A1 (en) 2001-01-26 2003-05-01 Henry Yue Intelectin
WO2002074156A2 (en) 2001-02-02 2002-09-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
US20040157278A1 (en) 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
US20040191782A1 (en) 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
WO2005015219A1 (en) * 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as marker for colorectal cancer
WO2005015218A1 (en) 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
EP1664787A1 (de) * 2003-08-08 2006-06-07 Roche Diagnostics GmbH Verwendung des proteins t-plastin (plst) als marker für kolorektalkarzinom
EP1723428A2 (de) 2004-02-19 2006-11-22 Yale University Corporation Identifizierung von krebsprotein-biomarkern unter verwendung von proteomtechniken
CN1669585A (zh) * 2004-03-19 2005-09-21 王健伟 一种肿瘤治疗剂及其用途
CA2569079A1 (en) 2004-06-03 2005-12-15 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US20090297523A1 (en) 2004-07-27 2009-12-03 Yale University Erm family binding agents and their use in diagnosis and treatment of proliferative conditions
AT500719B1 (de) 2004-09-08 2010-06-15 Red Bull Gmbh Chaperone als tumormarker
EP1838867B1 (de) 2005-01-06 2011-03-09 Eastern Virginia Medical School Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs
US20060192550A1 (en) 2005-02-25 2006-08-31 Sandquist David A Current sensor with magnetic toroid single frequency detection scheme
KR20080011287A (ko) * 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
EP1724586A3 (de) 2005-05-21 2007-07-04 ProteoSys AG Annexin für Krebsrisikomanagement
EP1910821B1 (de) 2005-06-24 2013-02-20 Ciphergen Biosystems, Inc. Biomarker für ovarialkarzinom
EP1861716A2 (de) 2005-08-18 2007-12-05 Zadec Aps Proteinmarker zur diagnose eines kolorektalkarzinoms und verwendung dieser marker als zielmoleküle für die behandlung dieses krebstyps
EP1775590A1 (de) 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Nicht invasive in vitro Methode zur Detektion von Transitionalzellkarzinomen der Harnblase
CN1967246A (zh) 2005-11-18 2007-05-23 上海中科新生命生物科技有限公司 酰化氨基酸水解酶1及其抗体检测肝癌的应用
WO2007068985A2 (en) 2005-12-16 2007-06-21 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
JP2009520957A (ja) * 2005-12-21 2009-05-28 エフ．ホフマン−ラ ロシュ アーゲー 便試料中のヘモグロビンおよびｍ２−ｐｋを測定することによる結腸直腸癌の評価方法
EP1966609A1 (de) * 2005-12-22 2008-09-10 Roche Diagnostics GmbH Verwendung einer markerkombination mit osteopontin und karzinoembryonalem antigen bei der beurteilung von kolorektalkarzinom
WO2007140352A2 (en) 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers
WO2008021290A2 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US8263344B2 (en) 2006-09-08 2012-09-11 Institut Gustave Roussy Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
EP2083857A4 (de) 2006-09-22 2010-03-24 Dana Farber Cancer Res Inc Verfahren zur behandlung von störungen in zusammenhang mit mica
EP2581458A3 (de) 2008-01-17 2013-07-17 Suregene LLC Genetische Marker von Geisteskrankheiten
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal

Also Published As

Publication number Publication date
WO2009019369A2 (fr) 2009-02-12
CA2695191A1 (fr) 2009-02-12
US8445211B2 (en) 2013-05-21
US20100136571A1 (en) 2010-06-03
AU2008285558A1 (en) 2009-02-12
FR2919061A1 (fr) 2009-01-23
JP5417327B2 (ja) 2014-02-12
CA2695191C (fr) 2019-06-25
EP2171466A2 (de) 2010-04-07
EP2171466B1 (de) 2012-02-15
AU2008285558B2 (en) 2014-05-08
JP2010533854A (ja) 2010-10-28
WO2009019369A3 (fr) 2009-04-09
CN101765774A (zh) 2010-06-30
CN101765774B (zh) 2013-11-06
FR2919061B1 (fr) 2009-10-02

Similar Documents

Publication Publication Date Title
WO2009019368A3 (fr) Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
WO2009024691A3 (fr) Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal
WO2009019367A3 (fr) Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
EP4293358A3 (de) Flüchtige organische verbindungen als krebs biomarker
MX2018011725A (es) Metodo para emplear expresion genica para determinar pronostico de cancer de prostata.
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
WO2009019365A3 (fr) Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal
DE602006018578D1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
NZ701208A (en) Immuno-pet imaging of antibodies and immunoconjugates and uses thereof
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
WO2014140933A8 (en) Method for the prognosis and treatment of cancer metastasis
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
EP4282405A3 (de) Nachweis von krebs-biomarkern mittels nanopartikeln
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
EP2212700B8 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
TW200626900A (en) Wnt proteins and detection and treatment of cancer
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal
ATE459883T1 (de) Neue proliferationsmarker in der klinischen praxis und deren verwendung zur krebsprognose oder -diagnose
GB2523211A8 (en) MCT protein inhibitor-related prognostic and therapeutic methods
DE60306517D1 (de) Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen